CCR5 and metabolic dysfunction-associated steatotic liver disease: Our results from adoptive g-MDSC transfer further confirmed that CCR5-deficient g-MDSCs reduced hepatic STAT3 activation and lipogenic gene expression without exacerbating liver injury in NAFLD.